The Axion team

Proven clinical access, scientific credibility, commercial execution

NHS partnerships and experienced clinical leadership, university research validation, and listed-company operators with a track record of product rollout.

Board, management & technical

Who is behind Axion Biomed

Daniel Honeywell
Board Member — strategy & investor relations
Tech founder and business leader with 15+ years building, scaling and advising high-growth companies, with deep expertise in the UK healthcare sector and category design.
Dr Etrur Albani
Board Member — commercial partnerships
Serial entrepreneur experienced in start-up and established businesses, turnaround and strategic development. PhD, London South Bank; Oxford Strategic Leadership, Saïd Business School.
Chris Gilbert
Board Member
Co-founder and former CEO of Fox Marble Holdings Plc, the first AIM-listed dimension stone company, leading it from inception in 2011 through to its 2023 reverse takeover.
Gabriel Coll Abrinas
Board Member
20+ years across renewable energy, insurance, food and construction. CEO of Quely Group, founder of Mediterranean Fusion Energy and EcoZenova, board director at Ribe Salat.
Brian Fenton
COO & Board Member
Nearly 30 years with Silicon Valley and Taiwan start-ups, helping high-technology companies scale internationally. Clients include SanDisk, Marvell/Galileo, Cypress Semiconductor, MStar and Amlogic.
Stephen Darren Magee
Board Member — Director of Innovation, clinical access & NHS trial lead
35+ years in decontamination sciences and infection control. Associate Director of Medical Physics and Clinical Engineering at St George's, Epsom & St Helier NHS Trust, and a strategic adviser within NHS England's London Regional Clinical Engineering Network.
Joseph Lew
Business Development Director
Began trading at 24, building international supply relationships with major UK wholesalers and cash & carry networks, later expanding into large-scale property development and land assembly with overseas and UK investors.
Thomas Melchior
CFO — financial oversight & clinical spend governance
Senior leadership experience as CEO/COO/CFO in technology-driven, customer-focused enterprises, running teams from small start-ups to organisations of 2,500 people. MBA, University of Rochester; Federal Diploma in Business Administration, Zurich.
Ian Cunningham
Head of Marketing
Seasoned sales and marketing professional with demonstrable success creating demand across major sales categories and international markets, with strengths in digital production and innovative B2B communications.
Prof. László Janovák
Scientific lead — ROS translation to clinical device settings
Lead scientist and assistant professor at the Department of Physical Chemistry and Materials Science, University of Szeged, specialising in polymer and composite thin films, photoreactive and superhydrophobic surfaces.
Dr Maali-Amel Mersel
R&D lead — GMP, clinical sample testing
Early-career researcher in environmental photochemistry. Stipendium Hungaricum scholar with a PhD from the University of Pannonia, now R&D Team Lead at Resysten Hungary, directing sustainable coating initiatives.